Description
Lemon Bottle is a special formulation consisting primarily of riboflavin (vitamin B2), lecithin and bromelain. The characteristic yellow color of the solution gives the compound its name. In research context, Lemon Bottle is used as a locally applied compound for lipolysis studies, with focus on tissue-specific adipocyte reduction.
The research mechanism combines multiple components. Riboflavin functions as a photoactive cofactor and is associated in the research hypothesis with increased mitochondrial activity in target cells. Lecithin as a phospholipid source addresses adipocyte membrane integrity. Bromelain as a proteolytic enzyme acts supportively in tissue modulation. The combination is expected in preclinical studies to trigger an adipocyte apoptosis cascade.
Lemon Bottle thus belongs to the family of locally applied lipolysis compounds, with a research profile similar to substantially more expensive compounds in this class. The data in scientific literature is limited; the compound is primarily established in application research in the Asian region.
In research setups, Lemon Bottle is particularly interesting for studies on localized adipocyte modulation, in contrast to systemically acting compounds like GLP-1 agonists or MOTS-C. Application routes in preclinical setups are typically local, not systemic.
Lemon Bottle is available in 10ml vials as 10-vial packs.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
Lemon Bottle is considered predominantly mild per study reports, since the components riboflavin, lecithin and bromelain are individually well characterized. As a locally applied compound, the documented profile concentrates on the application site.
Observed in studies and user reports:
- Local application site: redness, swelling, pressure, warmth or transient irritation in the treated tissue area is the most common observation with locally applied lipolysis compounds.
- Bromelain component: the proteolytic enzyme can in rare cases be associated with sensitivity reactions, as described in the literature on the bromelain family.
- Discoloration: the characteristic yellow riboflavin solution can cause transient discoloration at the application area.
- Limited data: the scientific literature on Lemon Bottle as a specific formulation is thin and robust human studies are lacking. The substance is primarily established in application research in the Asian region.
This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- Injectable treatments for adipose tissue: terminology, mechanism, and tissue interaction - Lasers in Surgery and Medicine 2009: Review of the class of fat-reducing injections, not of Lemon Bottle itself: distinguishes mesotherapy, injection lipolysis and adipolytic detergents such as deoxycholate and notes that none of these therapies had regulatory clearance at the time.
- Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution - Dermatologic Surgery 2004: Work on the lecithin component: in cell culture and porcine skin, an injectable phosphatidylcholine formulation acted mainly through the detergent sodium deoxycholate, which lyses cell membranes nonspecifically, rather than through phosphatidylcholine itself.
- Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes - PLoS One 2012: Work on the bromelain component: in 3T3-L1 cells, stem bromelain inhibited adipocyte differentiation and induced apoptosis and lipolysis in mature adipocytes.
- Riboflavin (vitamin B-2) and health - American Journal of Clinical Nutrition 2003: Work on the riboflavin component: review of the sources, status and health relevance of dietary vitamin B2; it contains no data on local lipolysis.
